As the leading specialty benefits management partner for today’s health care organizations, we help improve the quality of care and reduce costs for today’s most complex tests and treatments. On All Access, Benzinga partners with companies to bring you in-depth one-on-one conversations with executives across a wide range of industries and asset classes.ĪIM ImmunoTech Inc. At AIM Specialty Health (AIM), it’s our mission to promote appropriate, safe, and affordable health care. Benzinga All Access is a first-of-its-kind show: part interview, part investor presentation. The Benzinga All Access Show is a 2-hour talk-show event where a select number of companies are chosen to give a 20-minute interview to discuss their companies. An archived recording of the presentation will be available on the investor relations section of the AIM website at.
The event will be broadcast live and can be viewed here. Equels is scheduled to participate on Decemat 11:20 AM EST during the Benzinga All Access event.
#Aim executive inc series#
The BioFlorida conference will consist of a series of roundtable panel discussions that will be moderated by Maulik Shah, MD, PhD, from Applied Ingenuity Diagnostics.įor more information on the BioFlorida Conference, please visit or contact All-Access Event He will also be participating in the CEO Forum at 5:30 PM EST. AIM Executive Recruiting raised a total of 18 K in funding over 1 rounds. Equels will be participating in the "COVID-19: What’s Next in Prevention, Treatment & Diagnostics" panel taking place on Thursday, Decemat 1:45 PM EST during the BioFlorida Conference. Quote Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating Performance. (NYSE American: AIM) today announced that Thomas Equels, Chief Executive Officer of AIM, will be participating in two upcoming investor conferences. The class consists of all present and former non-shareholder employees. (ERISA), by employees to obtain benefits under an employee profit sharing retirement plan maintained by their employer, AIM Executive, Inc. 06, 2021 (GLOBE NEWSWIRE) - AIM ImmunoTech Inc. This is a class action brought under the Employee Retirement Income Security Act of 1974, as amended, 29 U.S.C.
0 kommentar(er)
